Esketamine injection just after childbirth reduces depression in new mothers

Low dose esketamine should be considered for individuals with depressive symptoms in pregnancy, say researchers A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds a clinical trial published by The BMJ today. The results ...

2024-06-04T10:23:45+00:0011 April 2024|Press release, The BMJ|

New documents reveal patient safety concerns over strike day cover

Investigation sheds new light on process designed to keep patients safe during industrial action BMA says it takes concerns around patient safety “incredibly seriously” An investigation published by The BMJ today reveals new details of requests to recall striking junior doctors from picket lines for patient safety reasons. Documents show ...

2025-06-26T08:04:42+00:0028 March 2024|Press release, The BMJ|

Many publicly accessible AI assistants lack adequate safeguards to prevent mass health disinformation

Effective processes for reporting and responding to safeguard vulnerabilities are also lacking, warn experts Many publicly accessible artificial intelligence (AI) assistants lack adequate safeguards to consistently prevent the mass generation of health disinformation across a broad range of topics, warn experts in The BMJ today. They call for enhanced regulation, ...

2024-06-04T10:23:17+00:0021 March 2024|Press release, The BMJ|
Go to Top